论文部分内容阅读
本文报告20例慢性肺源性心脏病(慢性肺心病)心衰患者治疗中加服硝苯吡啶(治疗组)与常规治疗组(对照组)肺动脉压(PAP)观测分析,结果显示治疗组PAP下降程度及心衰纠正时间明显优于对照组,现将疗效结果报告分析如下。
This paper reports 20 cases of patients with chronic heart disease (chronic pulmonary heart disease) heart failure patients treated with nifedipine (treatment group) and routine treatment group (control group) pulmonary artery pressure (PAP) observation and analysis showed that the treatment group PAP Descent and heart failure correction time was significantly better than the control group, now report the results of the treatment as follows.